Reuters: A panel of outside experts to the FDA, including David Blumenthal, assistant professor of medicine, unanimously voted against an experimental drug to prevent gout flares, based on trials that tested the drug for only 16 weeks. “A lot of the patients where we envision using this drug are going to take it for longer than 16 weeks. It’s hard for me to allow patients to be exposed (without longer safety data),” he said.
Medicine’s David Blumenthal sits on FDA expert panel reviewing gout drug
- Think[box] Manager Ian Charnas creates ”Waterfall Swing” with team
- History’s Gillian Weiss’ book featured for French translation
- Physics’ Mano Singham debates minister on existence of God
- Professor Emeritus Edward J. Olszewski publishes book on Parmigianino painting
- Modern Languages and Literatures’ Linda C. Ehrlich speaks in Israel on Japanese traditions